SNN Stock Analysis: Buy, Sell, or Hold?
SNN - Smith & Nephew plc
$34.14
0.48 (1.43%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
23d
Get Alerted When SNN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNN is fairly valued with market pricing in 0.4% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: SNN is fairly valued with market pricing in 0.4% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$48.81
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$30.31
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNN is currently trading at $34.14, which is considered extended relative to its 30-day fair value range of $32.59 to $33.67. The stock's valuation (Forward PE: 18.6) is in line with its historical norms (18.4). At these levels, the market is pricing in 0.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SNN is in a strong downtrend. The price is approaching resistance at $34.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SNN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNN is in a strong downtrend. The price is approaching resistance at $34.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SNN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$32.59 -
$33.67
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding SNN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($36.42)
- NEUTRAL: Market pricing in 0.4% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$32.59 -
$33.67
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$32.08
Resistance Level
$34.42
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
18.61
Wall Street Target
$36.42
(+8.2%)
Revenue Growth (YoY)
4.7%
Earnings Growth (YoY)
35.9%
Profit Margin
8.3%
Valuation Premium vs History
+0.4% premium
PE vs Historical
18.6 vs 18.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.4%
(market-implied from PE analysis)
1-Year Target
$33.79
(+0%)
2-Year Target
$33.93
(+1%)
3-Year Target
$34.07
(+1%)
3-Yr Target (if PE normalizes)
(PE: 19→18)
PE COMPRESSION
$33.68
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 12.0%)
$56.62
(+68%)
Base:
(SPY PE: 18.6, Growth: 12.0%)
$47.26
(+40%)
Bear:
(PE: 15.8, Growth: 12.0%)
$40.17
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 30.23 | Current EPS (TTM): $1.12
Bull Case
$60.15
(+76%)
Analyst growth 61.5%, PE expands to 33.3
Base Case
$54.68
(+60%)
Market implied 61.5%, PE stable at 30.2
Bear Case
$23.02
(-33%)
Severe decline -20.0%, PE contracts to 25.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 5:58 AM ET
Data refreshes hourly during market hours. Next update: 6:58 AM
Data refreshes hourly during market hours. Next update: 6:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced SNN Option Strategies
Professional options setups generated by AI based on today's SNN price and gamma walls.
